Cash & equivalents increased 75.7%
Cash & equivalents changed +75.7% from the comparable as-filed period.
$10.7M→$18.9M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PYXS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 5.5%
Operating cash flow changed -5.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$17.3M→-$18.2M4 prior comparisons
Research & development decreased 6.3%
Research & development changed -6.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$17.1M→$16.1M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.